Cargando…
Magnetic Lateral Flow Immunoassays
A new generation of magnetic lateral flow immunoassays is emerging as powerful tool for diagnostics. They rely on the use of magnetic nanoparticles (MNP) as detecting label, replacing conventional gold or latex beads. MNPs can be sensed and quantified by means of external devices, allowing the devel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278001/ https://www.ncbi.nlm.nih.gov/pubmed/32397264 http://dx.doi.org/10.3390/diagnostics10050288 |
_version_ | 1783543250067390464 |
---|---|
author | Moyano, Amanda Serrano-Pertierra, Esther Salvador, María Martínez-García, José Carlos Rivas, Montserrat Blanco-López, M. Carmen |
author_facet | Moyano, Amanda Serrano-Pertierra, Esther Salvador, María Martínez-García, José Carlos Rivas, Montserrat Blanco-López, M. Carmen |
author_sort | Moyano, Amanda |
collection | PubMed |
description | A new generation of magnetic lateral flow immunoassays is emerging as powerful tool for diagnostics. They rely on the use of magnetic nanoparticles (MNP) as detecting label, replacing conventional gold or latex beads. MNPs can be sensed and quantified by means of external devices, allowing the development of immunochromatographic tests with a quantitative capability. Moreover, they have an added advantage because they can be used for immunomagnetic separation (IMS), with improvements in selectivity and sensitivity. In this paper, we have reviewed the current knowledge on magnetic-lateral flow immunoassay (LFIA), coupled with both research and commercially available instruments. The work in the literature has been classified in two categories: optical and magnetic sensing. We have analysed the type of magnetic nanoparticles used in each case, their size, coating, crystal structure and the functional groups for their conjugation with biomolecules. We have also taken into account the analytical characteristics and the type of transduction. Magnetic LFIA have been used for the determination of biomarkers, pathogens, toxins, allergens and drugs. Nanocomposites have been developed as alternative to MNP with the purpose of sensitivity enhancement. Moreover, IMS in combination with other detection principles could also improve sensitivity and limit of detection. The critical analysis in this review could have an impact for the future development of magnetic LFIA in fields requiring both rapid separation and quantification. |
format | Online Article Text |
id | pubmed-7278001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72780012020-06-12 Magnetic Lateral Flow Immunoassays Moyano, Amanda Serrano-Pertierra, Esther Salvador, María Martínez-García, José Carlos Rivas, Montserrat Blanco-López, M. Carmen Diagnostics (Basel) Review A new generation of magnetic lateral flow immunoassays is emerging as powerful tool for diagnostics. They rely on the use of magnetic nanoparticles (MNP) as detecting label, replacing conventional gold or latex beads. MNPs can be sensed and quantified by means of external devices, allowing the development of immunochromatographic tests with a quantitative capability. Moreover, they have an added advantage because they can be used for immunomagnetic separation (IMS), with improvements in selectivity and sensitivity. In this paper, we have reviewed the current knowledge on magnetic-lateral flow immunoassay (LFIA), coupled with both research and commercially available instruments. The work in the literature has been classified in two categories: optical and magnetic sensing. We have analysed the type of magnetic nanoparticles used in each case, their size, coating, crystal structure and the functional groups for their conjugation with biomolecules. We have also taken into account the analytical characteristics and the type of transduction. Magnetic LFIA have been used for the determination of biomarkers, pathogens, toxins, allergens and drugs. Nanocomposites have been developed as alternative to MNP with the purpose of sensitivity enhancement. Moreover, IMS in combination with other detection principles could also improve sensitivity and limit of detection. The critical analysis in this review could have an impact for the future development of magnetic LFIA in fields requiring both rapid separation and quantification. MDPI 2020-05-08 /pmc/articles/PMC7278001/ /pubmed/32397264 http://dx.doi.org/10.3390/diagnostics10050288 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Moyano, Amanda Serrano-Pertierra, Esther Salvador, María Martínez-García, José Carlos Rivas, Montserrat Blanco-López, M. Carmen Magnetic Lateral Flow Immunoassays |
title | Magnetic Lateral Flow Immunoassays |
title_full | Magnetic Lateral Flow Immunoassays |
title_fullStr | Magnetic Lateral Flow Immunoassays |
title_full_unstemmed | Magnetic Lateral Flow Immunoassays |
title_short | Magnetic Lateral Flow Immunoassays |
title_sort | magnetic lateral flow immunoassays |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278001/ https://www.ncbi.nlm.nih.gov/pubmed/32397264 http://dx.doi.org/10.3390/diagnostics10050288 |
work_keys_str_mv | AT moyanoamanda magneticlateralflowimmunoassays AT serranopertierraesther magneticlateralflowimmunoassays AT salvadormaria magneticlateralflowimmunoassays AT martinezgarciajosecarlos magneticlateralflowimmunoassays AT rivasmontserrat magneticlateralflowimmunoassays AT blancolopezmcarmen magneticlateralflowimmunoassays |